Lipid raft redox signaling platforms in vascular dysfunction: Features and mechanisms

Current Atherosclerosis Reports

Volumn 11, Issue 3, 2009, Pages 220-226

  Jin, Si ^a   Zhou, Fan ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DETERGENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SUPEROXIDE;

CELL MEMBRANE RESISTANCE; ELECTRON SPIN RESONANCE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HYDROLYSIS; IMMUNOFLUORESCENCE TEST; IMMUNOLOCALIZATION; LIPID RAFT; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; POSITIVE FEEDBACK; REVIEW; SIGNAL TRANSDUCTION; ULTRACENTRIFUGATION; VASCULAR DISEASE;

ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE MICRODOMAINS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 65449165610     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-009-0034-6     Document Type: Review

References (49)

1. Lindsay AC, Choudhury RP: Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov 2008, 7: 517-529.
2. Hahn C, Schwartz MA: The role of cellular adaptation to mechanical forces in atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28: 2101-2107.
3. Verhoye E, Langlois MR: Review: Circulating oxidized low-density lipoprotein: A biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med 2008 (in press).
4. Dai G, Vaughn S, Zhang Y, et al.: Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 2007, 101: 723-733.
5. Meyer JW, Schmitt ME: A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett 2000, 472: 1-4.
6. Rueckschloss U, Duerrschmidt N, Morawietz H: NADPH oxidase in endothelial cells: Impact on atherosclerosis. Antioxid Redox Signal 2003, 5: 171-180.
7. Singer SJ, Nicholson GL: The fluid mosaic model of the structure of cell membrane. Science 1972, 175: 720-731.
8. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997, 387: 569-572.
9. Bollinger CR, Teichgraber V, Gulbins E: Ceramide-enriched membrane domains. Biochim Biophys Acta 2005, 1746: 284-294.
10. Zhang Y, Li X, Becker KA, et al.: Ceramide-enriched membrane domains-Structure and function. Biochim Biophys Acta 2009, 1788: 178-183.
11. Tuosto L, Parolini I, Schroder S, et al.: Organization of plasma membrane functional rafts upon T cell activation. Eur J Immunol 2001, 31: 345-349.
12. Schuck S, Simons K: Polarized sorRing in epithelial cells: raft clustering and the biogenesis of the apical membrane. J Cell Sci 2004, 117: 5955-5964.
13. Soong G, Reddy B, Sokol S, et al.: TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 2004, 113: 1482-1489.
14. Zhang AY, Yi F, Zhang G, et al.: Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006, 47: 74-80.
15. Ji SR, Ma L, Bai CJ, et al.: Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J 2009 (in press).
16. Sowa G, Xie L, Xu L, et al.: Serine 23 and 36 phosphorylation of caveolin-2 is differentially regulated by targeting to lipid raft/ caveolae and in mitotic endothelial cells. Biochemistry 2008, 47: 101-111.
17. Kulms D, Zeise E, Poppelmann B, et al.: DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene 2002, 21: 5844-5851.
18. Temkin V, Karin M: From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: The receptorinteracting protein 1 odyssey. Immunol Rev 2007, 220: 8-21.
19. Ichikawa D, Funakoshi-Tago M, Aizu-Yokota E, et al.: TNF-receptor associated factor 6-deficient fibroblast is sensitive to the TNF-alpha-induced cell death: Involvement of reactive oxygen species. Biochem Biophys Res Commun 2006, 351: 93-98.
20. Lin Y, Choksi S, Shen HM, et al.: Tumor necrosis factorinduced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 2004, 279: 10822-10828.
21. Cai H: NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 2005, 96: 818-822.
22. Griendling RK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86: 494-501.
23. Rajagopalan S, Kurz S, Munzel T, et al.: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996, 97: 1916-1923.
24. Gorlach A, Brandes RP, Nguyen K, et al.: A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000, 87(1): 26-32.
25. Cheng G, Cao Z, Cu X, et al.: Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001, 269: 131-140.
26. Berry C, Touyz R, Dominiczak AF, et al.: Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 2001, 281: H2337-2365.
27. Lassegue B, Sorescu D, Szocs K, et al.: Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001, 88: 888-894.
28. Brandes RP, KreuzerMJ: Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005, 65: 16-27.
29. Valencia A, Rajadurai A, Carle AB, et al.: 7-Dehydrocholesterol enhances ultraviolet A-induced oxidative stress in keratinocytes: Roles of NADPH oxidase, mitochondria, and lipid rafts. Free Radic Biol Med 2006, 41: 1704-1718.
30. Cahuzac N, Baum W, Kirkin V, et al.: Fas ligand is localized to membrane rafts, where it displays increased cell deathinducing activity. Blood 2006, 107: 2384-2391.
31. Charruyer A, Grazide S, Bezombes C, et al.: UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J Biol Chem 2005, 280: 19196-19204.
32. Jin S, Zhang Y, Yi F, et al.: Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 2008, 28: 485-490.
33. Gulbins E, Grassme H: Ceramide and cell death receptor clustering. Biochim Biophys Acta 2002, 1585: 139-145.
34. Jin S, Yi F, Zhang F, et al.: Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol 2008, 28: 2056-2062.
35. Cremesti AE, Goni FM, Kolesnick R: Role of sphingomyelinase and ceramide in modulating rafts: Do biophysical properties determine biologic outcome? FEBS Lett 2002, 531: 47-53.
36. Jin S, Yi F, Li PL: Contribution of lysosomal vesicles to the formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 2007, 9: 1417-1426.
37. Zuo L, Ushio-Fukai M, Ikeda S, et al.: Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: Role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 2005, 25: 1824-1830.
38. Gulbins E, Kolesnick R: Raft ceramide in molecular medicine. Oncogene 2003, 22: 7070-7077.
39. SchePck M, Carpinteiro A, Grassme H, et al.: Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys 2007, 462: 171-175.
40. Zhang AY, Yi F, Jin S, et al.: Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 2007, 9: 817-828.
41. Marchesini N, Hannun YA: Acid Rnd neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 2004, 82: 27-44.
42. Kim S, Zhang L: Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine. J Immunol Methods 2005, 298: 1-8.
43. Li PL, Zhang Y, Yi F: Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal 2007, 9: 1457-1470.
44. Berruet L, Muller-Steffner H, Schuber F: Occurrence of bovine spleen CD38/NAD+glycohydrolase disulfide-linked dimers. Biochem Mol Biol Int 1998, 46: 847-855.
45. Finkel T: Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 1999, 65: 337-340.
46. Qiu H, Edmunds T, Baker-Malcolm J, et al.: Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J Biol Chem 2003, 278: 32744-32752.
47. Powers KA, Szaszi K, Khadaroo RG, et al.: Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 2006, 203: 1951-1961.
48. Pober JS, Min W: Endothelial cell dysfunction, injury and death. Handbook Exp Pharmacol 2006, 176: 135-156.
49. Pober JS, Min W, Bradley JR: Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2008 (in press).